However, most GLP-1 medications are still under patent protection, limiting competitive pricing pressure
Yes, semaglutide (the active ingredient in Ozempic, Wegovy, Rybelsus, and other GLP-1 drugs) is well-known for causing GI side effects
If those pellets concern you, raise it before the treatment plan is finalised
Your Body's Response: We monitor how you feel every step of the way, because your feedback is a critical part of the journey
Cool Down: A drop in core body temperature signals the brain to sleep
Additionally, semaglutide may be subject to volume-based procurement (VBP) as the biosimilars/generics entry could be as early as 2026, potentially impacting the pricing of Ozempic and Wegovy